Cargando…

Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2

BACKGROUND: Antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been shown to neutralize the virus in vitro and prevent disease in animal challenge models on reexposure. However, the current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grandjean, Louis, Saso, Anja, Torres Ortiz, Arturo, Lam, Tanya, Hatcher, James, Thistlethwayte, Rosie, Harris, Mark, Best, Timothy, Johnson, Marina, Wagstaffe, Helen, Ralph, Elizabeth, Mai, Annabelle, Colijn, Caroline, Breuer, Judith, Buckland, Matthew, Gilmour, Kimberly, Goldblatt, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994590/ https://www.ncbi.nlm.nih.gov/pubmed/34218284 http://dx.doi.org/10.1093/cid/ciab607

Ejemplares similares

The Influence of Time on the Sensitivity of SARS-CoV-2 Serological Testing
por: Ortiz, Arturo Torres, et al.
Publicado: (2022)

The influence of time on the sensitivity of SARS-CoV-2 serological testing
por: Torres Ortiz, Arturo, et al.
Publicado: (2022)

Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2
por: Johnson, Marina, et al.
Publicado: (2020)

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
por: Upasani, Vinit, et al.
Publicado: (2023)

Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination
por: Wagstaffe, Helen R, et al.
Publicado: (2019)

The Development of Immunological Assays to Evaluate the Level and Function of Antibodies Induced by Klebsiella pneumoniae O-Antigen Vaccines
por: Wagstaffe, Helen R., et al.
Publicado: (2023)

(667) Antibody Response to Sars-Cov-2 Vaccination in Adolescents Following Solid Organ Transplantation
por: Brugha, R., et al.
Publicado: (2023)

Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey
por: Swartz, Michael D, et al.
Publicado: (2022)

Antibodies Produced in Response to a Live-Attenuated Dengue Vaccine Are Functional in Activating the Complement System
por: Nascimento, Eduardo J M, et al.
Publicado: (2022)

The Antibody Response to SARS-CoV-2 Infection
por: Hueston, Linda, et al.
Publicado: (2020)

Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2021)

Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
por: Brown, Jennifer A, et al.
Publicado: (2023)

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines
por: Swanstrom, Jesica A, et al.
Publicado: (2019)

Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus
por: Fisher, Dennis G., et al.
Publicado: (2015)

Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia
por: Hlupeni, Admire, et al.
Publicado: (2018)

Reduced Transplacental Transfer of Antimalarial Antibodies in Kenyan HIV-Exposed Uninfected Infants
por: Ray, Jessica E, et al.
Publicado: (2019)

Difficulties of Identifying the Early HIV Antibody Seroconversion Period Depending on the Confirmatory Assay
por: Stefic, Karl, et al.
Publicado: (2020)

Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials
por: Lofgren, Sarah M, et al.
Publicado: (2021)

Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection
por: Spatola, Marianna, et al.
Publicado: (2022)

Seroprevalence and Correlates of SARS-CoV-2 Antibodies in Health Care Workers in Chicago
por: Wilkins, John T, et al.
Publicado: (2020)

Dynamic Change and Clinical Relevance of Postinfectious SARS-CoV-2 Antibody Responses
por: Mallon, Patrick W G, et al.
Publicado: (2021)

Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers
por: Brant-Zawadzki, Michael, et al.
Publicado: (2021)

Comparative Efficacy of Early COVID-19 Monoclonal Antibody Therapies: A Retrospective Analysis
por: San Filippo, Savanna, et al.
Publicado: (2022)

Mumps Serum Antibody Levels Before and After an Outbreak to Assess Infection and Immunity in Vaccinated Students
por: Gouma, Sigrid, et al.
Publicado: (2014)

Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China
por: Kmush, Brittany L, et al.
Publicado: (2019)

Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19
por: Webb, Brandon J, et al.
Publicado: (2021)

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01(E) Malaria Vaccine( )
por: Sagara, Issaka, et al.
Publicado: (2021)

Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection
por: Tomasi, Lisa, et al.
Publicado: (2022)

Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers
por: Davies, Bethan, et al.
Publicado: (2021)

Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults
por: Eiden, Joseph, et al.
Publicado: (2022)

Mumps Antibody Response in Young Adults After a Third Dose of Measles-Mumps-Rubella Vaccine
por: Fiebelkorn, Amy Parker, et al.
Publicado: (2014)

Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans
por: Zhong, Weimin, et al.
Publicado: (2016)

Characterization of Anti–Interferon-γ Antibodies in HIV-Negative Patients Infected With Disseminated Talaromyces marneffei and Cryptococcosis
por: Zeng, Wen, et al.
Publicado: (2019)

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients
por: Piccicacco, Nicholas, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs in the Presence of Antibodies
por: Bean, David J, et al.
Publicado: (2021)

Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience
por: Ousmane, Sani, et al.
Publicado: (2021)

Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia
por: Cutts, Julia C, et al.
Publicado: (2022)

Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial
por: Fong, Youyi, et al.
Publicado: (2023)

IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity
por: Wang, Jiong, et al.
Publicado: (2022)

T-cell responses to SARS-CoV-2 in healthy controls and primary immunodeficiency patients
por: Awuah, Arnold, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cnceb1s2lcd0ij0716i8hn0s4s